Causes and consequences of methamphetamine and MDMA toxicity

No abstract is available for this paper.

• Publication year

  2006

• Venue

  AAPS Journal

• Publication date

  2006-05-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02854904PMID 16796384PMCID PMC3231568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methamphetamine‐induced spectrin proteolysis in the rat striatum

  2006cited by this paper
• Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra.

  2006cited by this paper
• L-Tyrosine Contributes to (+)-3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletions

  2006cited by this paper
• Glutamate‐mediated influx of extracellular Ca2+ is coupled with reactive oxygen species generation in cultured hippocampal neurons but not in astrocytes

  2005cited by this paper
• Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity

  2005cited by this paper
• Excitotoxic Injury to Mitochondria Isolated from Cultured Neurons*

  2005cited by this paper
• Methamphetamine‐induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite

  2005cited by this paper
• Evidence for the Involvement of Nitric Oxide in 3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletion in the Rat Brain

  2005cited by this paper
• Neurotoxic regimens of methamphetamine induce persistent expression of phospho‐c‐Jun in somatosensory cortex and substantia nigra

  2005cited by this paper
• Lobeline Attenuates Methamphetamine-Induced Changes in Vesicular Monoamine Transporter 2 Immunoreactivity and Monoamine Depletions in the Striatum

  2005cited by this paper
• The Blood-Brain Barrier/Neurovascular Unit in Health and Disease

  2005cited by this paper
• Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin

  2005cited by this paper
• High-Dose Methamphetamine Acutely Activates the Striatonigral Pathway to Increase Striatal Glutamate and Mediate Long-Term Dopamine Toxicity

  2004cited by this paper
• Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

  2004cited by this paper
• Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine

  2004cited by this paper
• Thioether Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Inhibit Human Serotonin Transporter (hSERT) Function and Simultaneously Stimulate Dopamine Uptake into hSERT-Expressing SK-N-MC Cells

  2004cited by this paper
• Reactions of the putative neurotoxin tryptamine-4,5-dione with L-cysteine and other thiols.

  2004cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress.

  2003cited by this paper
• Methamphetamine-Induced Degeneration of Dopaminergic Neurons Involves Autophagy and Upregulation of Dopamine Synthesis

  2002cited by this paper
• Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.

  2002cited by this paper
• Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat

  2002cited by this paper
• Selective Blockade of mGlu5 Metabotropic Glutamate Receptors Is Protective against Methamphetamine Neurotoxicity

  2002cited by this paper
• 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.

  2002cited by this paper
• Peroxynitrite-induced Nitration of Tyrosine Hydroxylase IDENTIFICATION OF TYROSINES 423, 428, AND 432 AS SITES OF MODIFICATION BY MATRIX-ASSISTED LASER DESORPTION IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY AND TYROSINE-SCANNING MUTAGENESIS*

  2002cited by this paper
• Peroxynitrite-induced Nitration of Tyrosine Hydroxylase

  2002cited by this paper
• Enhancement of 3,4‐methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate

  2001cited by this paper
• Effects of repeated systemic administration of d-Fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis

  2001cited by this paper
• Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.

  2001cited by this paper
• Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

  2001cited by this paper
• Methamphetamine‐Induced Dopaminergic Neurotoxicity: Role of Peroxynitrite and Neuroprotective Role of Antioxidants and Peroxynitrite Decomposition Catalysts

  2001cited by this paper
• Ascorbic acid prevents 3,4‐methylenedioxymethamphetamine (MDMA)‐induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5‐HT

  2001cited by this paper
• A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

  2001cited by this paper
• Methamphetamine Rapidly Decreases Vesicular Dopamine Uptake

  2000cited by this paper
• Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration.

  2000cited by this paper
• Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines.

  2000cited by this paper
• Molecular mechanisms of calcium-dependent excitotoxicity

  2000cited by this paper
• Mazindol Attenuates the 3,4‐Methylenedioxymethamphetamine‐Induced Formation of Hydroxyl Radicals and Long‐Term Depletion of Serotonin in the Striatum

  1999cited by this paper
• Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.

  1999cited by this paper
• D-amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment.

  1999cited by this paper
• Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum.

  1998cited by this paper
• The Effects of Methamphetamine on the Production of Free Radicals and Oxidative Stress 1

  1998cited by this paper
• The effects of methamphetamine on the production of free radicals and oxidative stress.

  1998cited by this paper
• Methamphetamine neurotoxicity: Dissociation of striatal dopamine terminal damage from parietal cortical cell body injury

  1998cited by this paper
• Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

  1998cited by this paper
• An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

  1998cited by this paper
• Substrates of Energy Metabolism Attenuate Methamphetamine‐Induced Neurotoxicity in Striatum

  1998cited by this paper
• Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.

  1998cited by this paper
• Characterizing cortical neuron injury with fluoro‐jade labeling after a neurotoxic regimen of methamphetamine

  1998cited by this paper
• Methamphetamine alters presynaptic glutamate immunoreactivity in the caudate nucleus and motor cortex

  1997cited by this paper
• Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration.

  1997cited by this paper
• In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

  1997cited by this paper
• Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP.

  1996cited by this paper
• Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions

  1996cited by this paper
• The Neuronal Nitric Oxide Synthase Inhibitor, 7‐Nitroindazole, Protects Against Methamphetamine‐Induced Neurotoxicity In Vivo

  1996cited by this paper
• Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

  1996cited by this paper
• Effects of Glutamate Antagonists on Methamphetamine and 3,4‐Methylenedioxymethamphetamine‐Induced Striatal Dopamine Release In Vivo

  1996cited by this paper
• No .NO from NO synthase.

  1996cited by this paper
• Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.

  1995cited by this paper
• The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.

  1995cited by this paper
• The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.

  1995cited by this paper
• Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.

  1995cited by this paper
• Free radical-induced endothelial membrane dysfunction at the site of blood-brain barrier: Relationship between lipid peroxidation, Na,K-ATPase activity, and51Cr release

  1995cited by this paper
• Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of Methamphetamine

  1995cited by this paper
• Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic Neurotoxicity

  1994cited by this paper
• The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.

  1994cited by this paper
• 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.

  1994cited by this paper
• Methamphetamine‐induced neurotoxicity: Roles for glutamate and dopamine efflux

  1994cited by this paper
• Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

  1994cited by this paper
• Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.

  1994cited by this paper
• Excitatory amino acids as a final common pathway for neurologic disorders.

  1994cited by this paper
• Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

  1992cited by this paper
• The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole.

  1992cited by this paper
• Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture

  1990cited by this paper
• Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.

  1990cited by this paper
• Neurochemical basis of neurotoxicity.

  1990cited by this paper
• Long-term effects of chronic methamphetamine administration in rhesus monkeys.

  1989cited by this paper
• Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites.

  1989cited by this paper
• Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

  1989cited by this paper
• Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage

  1989cited by this paper
• Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.

  1988cited by this paper
• Orally administered MDMA causes a long-term depletion of serotonin in rat brain.

  1988cited by this paper
• Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

  1988cited by this paper
• (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.

  1988cited by this paper
• Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

  1987cited by this paper
• Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

  1987cited by this paper
• 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

  1987cited by this paper
• Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion.

  1986cited by this paper
• Role of dopamine in the neurotoxic effects of methamphetamine.

  1985cited by this paper
• Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain.

  1982cited by this paper
• Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.

  1980cited by this paper
• Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study.

  1980cited by this paper
• Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.

  1980cited by this paper
• Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.

  1979cited by this paper
• The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities.

  1979cited by this paper
• Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.

  1976cited by this paper

• Successful treatment of intractable MDMA adverse reactions using acupuncture and traditional Chinese medicine

  2025cites this paper
• Chronic, Low-Dose Methamphetamine Reveals Sexual Dimorphism of Memory Performance, Histopathology, and Gene Expression Affected by HIV-1 Tat Protein in a Transgenic Model of NeuroHIV

  2025cites this paper
• Whole-Cell Fiber-Optic Biosensor for Real-Time, On-Site Sediment and Water Toxicity Assessment: Applications at Contaminated Sites Across Israel

  2025cites this paper
• Ultra-low doses of methamphetamine suppress 5-hydroxytryptophan-induced head-twitch response in mice during aging

  2024cites this paper
• Rapid Separation and Detection of Drugs in Complex Biological Matrix Using TD-CDI Mass Spectrometer

  2024cites this paper
• Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex

  2023cites this paper
• Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder

  2023cites this paper
• Melatonin enhances the restoration of neurological impairments and cognitive deficits during drug withdrawal in methamphetamine-induced toxicity and endoplasmic reticulum stress in rats.

  2023cites this paper
• Long-term methamphetamine self-administration increases mesolimbic mitochondrial oxygen consumption and decreases striatal glutathione.

  2023cites this paper
• Methamphetamine Exposure During Pregnancy: A Meta-Analysis of Child Developmental Outcomes.

  2022cites this paper
• Knockout of Dopamine D3 Receptor Gene Blocked Methamphetamine-Induced Distinct Changes of Dopaminergic and Glutamatergic Synapse in the Nucleus Accumbens Shell of Mice

  2022cites this paper
• Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir

  2022cites this paper
• Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies.

  2022cites this paper
• Methamphetamine Self-Administration Differential Effects on Mesolimbic Glutathione Levels, Mitochondrial Respiration and Dopamine Neuron Firing Activity

  2022cites this paper
• COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population

  2022cites this paper
• Effect of the Sargassum angustifolium Extract on Methamphetamine-Induced Cytotoxicity in SH-SY5Y Cells

  2022cites this paper
• Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity

  2021cites this paper
• Neurotoxicity of MDMA: Main effects and mechanisms.

  2021cites this paper
• The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration

  2021cites this paper
• The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity

  2021cites this paper
• Neurotoxicity in Psychostimulant and Opiate Addiction

  2021cites this paper
• TBHQ-Overview of Multiple Mechanisms against Oxidative Stress for Attenuating Methamphetamine-Induced Neurotoxicity

  2020cites this paper
• The Challenge by Multiple Environmental and Biological Factors Induce Inflammation in Aging: Their Role in the Promotion of Chronic Disease

  2020cites this paper
• Substances of abuse and the blood brain barrier: Interactions with physical exercise.

  2020cites this paper
• The induction of Neuron-Glial2 (NG2) expressing cells in methamphetamine toxicity-induced neuroinflammation in rat brain are averted by melatonin.

  2020cites this paper
• Influence of Prenatal Methamphetamine Abuse on the Brain

  2020cites this paper
• The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use.

  2020cites this paper
• Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans

  2020cites this paper
• Molecular toxicological mechanisms of new psychoactive substances "in vitro"

  2020cites this paper
• Stimulanzien vom Amphetamin-Typ

  2019cites this paper
• Function of complement factor H and imaging of small molecules by MALDI‐MSI in a methamphetamine behavioral sensitization model

  2019cites this paper
• Methamphetamine‐associated difficulties in cognitive control allocation may normalize after prolonged abstinence

  2019cites this paper
• Rodent Models of Methamphetamine Misuse: Mechanisms of Methamphetamine Action and Comparison of Different Rodent Paradigms.

  2019cites this paper
• Methamphetamine Users Show No Behavioral Deficits in Response Selection After Protracted Abstinence

  2019cites this paper
• Identification of cytotoxic markers in methamphetamine treated rat C6 astroglia-like cells

  2019cites this paper
• Terapeutyczne zastosowanie wybranych substancji psychoaktywnych

  2019cites this paper
• Effect of a binge‐like dosing regimen of methamphetamine on dopamine levels and tyrosine hydroxylase expressing neurons in the rat brain

  2019cites this paper
• Time and region-dependent manner of increased Brain Derived Neurotrophic Factor and TrkB in rat brain after binge-like methamphetamine exposure.

  2019cites this paper
• Crocin Inhibits Apoptosis and Astrogliosis of Hippocampus Neurons Against Methamphetamine Neurotoxicity via Antioxidant and Anti-inflammatory Mechanisms

  2018cites this paper
• Concurrence of autophagy with apoptosis in alveolar epithelial cells contributes to chronic pulmonary toxicity induced by methamphetamine

  2018cites this paper
• Involvement of Mitochondrial Dysfunction on the Toxic Effects Caused by Drugs of Abuse and Addiction

  2018cites this paper
• Inflammasome Activation by Methamphetamine Potentiates Lipopolysaccharide Stimulation of IL-1β Production in Microglia

  2018cites this paper
• Role of aquaporin-4 in methamphetamine-induced blood-brain barrier dysfunction and cerebral edema formation

  2017cites this paper
• First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects.

  2017cites this paper
• The neurostructural effects of prenatal exposure to methamphetamine in an infant population in the Western Cape

  2017cites this paper
• Amphetamine‐related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

  2017cites this paper
• Prenatal methamphetamine exposure is associated with reduced subcortical volumes in neonates.

  2017cites this paper
• Axonal Transport, Parkin, And Α-Synuclein; Novel Therapeutic Targets To Treat Methamphetamine Neurotoxicity

  2017cites this paper
• Defining novel mediators and mechanisms of neural microvasculature permeability

  2017cites this paper
• The Role of Oxidative Stress in Methamphetamine-induced Toxicity and Sources of Variation in the Design of Animal Studies

  2017cites this paper
• Additive Effects of Former Methylenedioxymethamphetamine and Cannabis Use on Subclinical Psychotic Symptoms.

  2017cites this paper
• Endoplasmic reticulum stress and apoptosis via PERK-eIF2α-CHOP signaling in the methamphetamine-induced chronic pulmonary injury.

  2017cites this paper
• A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases

  2017cites this paper
• The effect of maternal exposure to methamphetamine during pregnancy and lactation period on hippocampal neurons apoptosis in rat offspring

  2017cites this paper
• Role of microglia in methamphetamine-induced neurotoxicity.

  2017cites this paper
• Tripping the light fantastic: Modeling the consequences of recreational use of MDMA or 5-MeO-DIPT in humans using weekend “rave” exposures in rat.

  2016cites this paper
• Cysteine residues reduce the severity of dopamine electrochemical fouling

  2016cites this paper
• Nutraceuticals against Neurodegeneration: A Mechanistic Insight

  2016cites this paper
• Effect of Simultaneous Use of Ritalin with Grape Seed Extract on Passive Avoidance Learning in Adult Male Rats

  2016cites this paper
• Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.

  2016cites this paper
• Mitochondrial Trails in the Neurotoxic Mechanisms of MDMA

  2016cites this paper
• Conditioned taste aversions: From poisons to pain to drugs of abuse

  2016cites this paper
• Fetal programming of neuropsychiatric disorders.

  2016cites this paper
• The blood-brain barrier and methamphetamine: open sesame?

  2015cites this paper
• Effect of prenatal methamphetamine administration during gestational days on mice

  2015cites this paper
• In vivo analysis of a salt bridge at the external gate of the Drosophila melanogaster serotonin transporter in response to amphetamines

  2015cites this paper
• Assessment of prospective and working memory in methamphetamine-dependent and withdrawn individuals

  2015cites this paper
• The Role of E3 Ligase Parkin in Trafficking of Monoamine Storage Vesicles in Rat Model of Methamphetamine Neurotoxicity

  2015cites this paper
• mRNA and microRNA analysis reveals modulation of biochemical pathways related to addiction in the ventral tegmental area of methamphetamine self-administering rats

  2015cites this paper
• Cardiovascular Toxicity as a Result of Recreational Drugs

  2015cites this paper
• Melatonin attenuates the mitochondrial translocation of mitochondrial fission proteins and Bax, cytosolic calcium overload and cell death in methamphetamine-induced toxicity in neuroblastoma SH-SY5Y cells.

  2015cites this paper
• Mitochondria: key players in the neurotoxic effects of amphetamines

  2015cites this paper
• Chronic wheel running reduces maladaptive patterns of methamphetamine intake: regulation by attenuation of methamphetamine-induced neuronal nitric oxide synthase

  2014cites this paper
• Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.

  2014cites this paper
• The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.

  2014cites this paper
• Methamphetamine Alters the Normal Progression by Inducing Cell Cycle Arrest in Astrocytes

  2014cites this paper
• Cognitive functions in methamphetamine induced psychosis compared to schizophrenia and normal subjects

  2014cites this paper
• Age-Related Differences in NMDA Receptor Subunits of Prenatally Methamphetamine-Exposed Male Rats

  2014cites this paper
• Neuronal Mitochondrial Trafficking Impairment: The Cause or a Consequence of Neuronal Dysfunction Caused by Amphetamine-Like Drugs

  2014cites this paper
• Fetal programming of the human brain: is there a link with insurgence of neurodegenerative disorders in adulthood?

  2014cites this paper
• Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.

  2014cites this paper
• LOBELANE ANALOGS WITH VARIOUS METHYLENE LINKER LENGTHS AND ACYCLIC LOBELANE ANALOGS AS POTENTIAL PHARMACOTHERAPIES TO TREAT METHAMPHETAMINE ABUSE

  2014cites this paper
• Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor

  2014cites this paper
• Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

  2014cites this paper
• Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.

  2014cites this paper
• Glial modulators as potential treatments of psychostimulant abuse.

  2014cites this paper
• Subchronic apocynin treatment attenuates methamphetamine-induced dopamine release and hyperactivity in rats.

  2014cites this paper
• Co‐administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats

  2014cites this paper
• MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner

  2014cites this paper
• Dottorato di Ricerca in Tossicologia - Indirizzo Farmacologia e Farmacoterapia delle Tossicodipendenze Ciclo XXVI

  2013cites this paper
• Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

  2013cites this paper
• Induction of mitochondrial permeability transition (MPT) pore opening and ROS formation as a mechanism for methamphetamine-induced mitochondrial toxicity

  2013cites this paper
• Methamphetamine-induced nitric oxide promotes vesicular transport in blood–brain barrier endothelial cells

  2013cites this paper
• Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans.

  2013cites this paper
• Response of glioblastoma cells to doxorubicin and methotrexate : role of methamphetamine

  2013cites this paper
• Oxidative Stress and Drugs of Abuse: An Update

  2013cites this paper
• Acute and chronic toxicity of methamphetamine exposure in cultured neuronal cells

  2013cites this paper
• Ecstasy¿s Neurotoxicity: In Vitro Findings from Mitochondria to the Cell

  2013cites this paper
• A prospective study of learning, memory, and executive function in new MDMA users.

  2013cites this paper
• Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain.

  2013cites this paper